{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:50:23Z","timestamp":1791996623822,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["G824310359"],"award-info":[{"award-number":["G824310359"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.116938","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:47:48Z","timestamp":1780458468000},"page":"116938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Kirenol, a diterpene active component from Siegesbeckia orientalis, alleviates atopic dermatitis by suppressing TYK2"],"prefix":"10.1016","volume":"184","author":[{"given":"Ziye","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuecheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehuang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116938_bb0005","doi-asserted-by":"crossref","first-page":"1361005","DOI":"10.3389\/fimmu.2024.1361005","article-title":"Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches","volume":"15","author":"Afshari","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116938_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-031-54513-9_4","article-title":"Clinical Presentation of Atopic Dermatitis","volume":"1447","author":"Ahn","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"issue":"14","key":"10.1016\/j.intimp.2026.116938_bb0015","doi-asserted-by":"crossref","first-page":"11528","DOI":"10.3390\/ijms241411380","article-title":"Challenges and Future Trends in Atopic Dermatitis","volume":"24","author":"Gatmaitan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116938_bb0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.anai.2025.05.003","article-title":"Current updates in the epidemiology and comorbidities of atopic dermatitis","volume":"135","author":"Narla","year":"2025","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116938_bb0025","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/ced\/llaf233","article-title":"Epidemiology of atopic dermatitis: a global worldwide study","volume":"50","author":"Skayem","year":"2025","journal-title":"Clin. Exp. Dermatol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116938_bb0030","first-page":"590","article-title":"Atopic Dermatitis: Diagnosis and Treatment","volume":"101","author":"Frazier","year":"2020","journal-title":"Am. Fam. Physician"},{"issue":"5","key":"10.1016\/j.intimp.2026.116938_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.anai.2025.06.020","article-title":"New treatments in atopic dermatitis update","volume":"135","author":"Gallagher","year":"2025","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116938_bb0040","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s10787-024-01453-8","article-title":"Atopic dermatitis: treatment and innovations in immunotherapy","volume":"32","author":"Ferrara","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.intimp.2026.116938_bb0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pop.2022.12.004","article-title":"Atopic Dermatitis","volume":"50","author":"Clebak","year":"2023","journal-title":"Prim. Care"},{"issue":"10478","key":"10.1016\/j.intimp.2026.116938_bb0050","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","article-title":"Atopic dermatitis","volume":"405","author":"Guttman-Yassky","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2026.116938_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-025-00313-3","article-title":"Atopic dermatitis: diagnosis, molecular pathogenesis, and therapeutics","volume":"6","author":"Bai","year":"2025","journal-title":"Mol. Biomed."},{"issue":"3","key":"10.1016\/j.intimp.2026.116938_bb0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4140\/TCP.n.2025.123","article-title":"Atopic Dermatitis in Adults: Focus on Topical Therapy","volume":"40","author":"Marshall","year":"2025","journal-title":"Sr Care Pharm."},{"issue":"4","key":"10.1016\/j.intimp.2026.116938_bb0065","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3390\/ijms24043391","article-title":"Tyk2 Targeting in Immune-Mediated Inflammatory Diseases","volume":"24","author":"Rusi\u00f1ol","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.intimp.2026.116938_bb0070","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2217\/imt-2022-0109","article-title":"Deucravacitinib in moderate-to-severe psoriasis","volume":"14","author":"Vu","year":"2022","journal-title":"Immunotherapy"},{"issue":"10","key":"10.1016\/j.intimp.2026.116938_bb0075","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/13543784.2024.2391825","article-title":"Recent progress in tyrosine kinase 2 inhibitors for atopic dermatitis","volume":"33","author":"Liu","year":"2024","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"6","key":"10.1016\/j.intimp.2026.116938_bb0080","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/bjd.21826","article-title":"Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study","volume":"187","author":"Landis","year":"2022","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116938_bb0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41584-024-01093-w","article-title":"TYK2: an emerging therapeutic target in rheumatic disease","volume":"20","author":"Morand","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2026.116938_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114117","article-title":"Herba Siegesbeckiae: A review on its traditional uses, chemical constituents, pharmacological activities and clinical studies","volume":"275","author":"Wang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.116938_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115939","article-title":"Research progress in arthritis treatment with the active components of Herba siegesbeckiae","volume":"169","author":"Lv","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.intimp.2026.116938_bb0100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/molecules27030734","article-title":"Kirenol: A Potential Natural Lead Molecule for a New Drug Design, Development, and Therapy for Inflammation","volume":"27","author":"Nasir","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116938_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153377","article-title":"Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca(2+)-NFATc1 and Cav-1 signaling pathways","volume":"80","author":"Zou","year":"2021","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.intimp.2026.116938_bb0110","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10753-023-01943-x","article-title":"Characterization of Different Inflammatory Skin Conditions in a Mouse Model of DNCB-Induced Atopic Dermatitis","volume":"47","author":"Riedl","year":"2024","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.intimp.2026.116938_bb0115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/17512433.2023.2219054","article-title":"TYK2 as a novel therapeutic target in psoriasis","volume":"16","author":"Elyoussfi","year":"2023","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116938_bb0120","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1002\/ptr.70056","article-title":"Advances in Atopic Dermatitis Treatment: From Pathogenesis to Natural Product-Based Therapies","volume":"39","author":"Fan","year":"2025","journal-title":"Phytother. Res."},{"issue":"10","key":"10.1016\/j.intimp.2026.116938_bb0125","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.4103\/jfmpc.jfmpc_112_24","article-title":"JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician","volume":"13","author":"Beard","year":"2024","journal-title":"J. Family Med. Prim. Care"},{"issue":"5","key":"10.1016\/j.intimp.2026.116938_bb0130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.25259\/IJDVL_775_2023","article-title":"Comparative efficacy and safety of JAK\/TYK2 inhibitors and other oral drugs for moderate-to-severe plaque psoriasis: Systematic review and network meta-analysis","volume":"90","author":"Zheng","year":"2024","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.intimp.2026.116938_bb0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.freeradbiomed.2025.03.022","article-title":"Kirenol alleviates cerebral ischemia-reperfusion injury by reducing oxidative stress and ameliorating mitochondrial dysfunction via activating the CK2\/AKT pathway","volume":"232","author":"Zhang","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116938_bb0140","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5586","article-title":"Kirenol relieves rheumatoid arthritis by targeting the TWEAK\/Fn14 pathway","volume":"56","author":"Chen","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116938_bb0145","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1080\/13880209.2022.2112239","article-title":"Kirenol alleviates diabetic nephropathy via regulating TGF-\u03b2\/Smads and the NF-\u03baB signal pathway","volume":"60","author":"Li","year":"2022","journal-title":"Pharm. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116938_bb0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/0113862073289977240216075724","article-title":"Pharmacological Mechanisms of Kirenol against Ovarian Carcinoma: A Network Pharmacology and Experimental Validation Study In Vitro","volume":"28","author":"Mao","year":"2025","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"3","key":"10.1016\/j.intimp.2026.116938_bb0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5152\/j.aott.2020.03.529","article-title":"Effect of Kirenol on the interaction between the WNT\/\u03b2-Catenin and RUNX2\/TCF\/LEF1 pathways in fracture healing in vivo","volume":"54","author":"Karaman","year":"2020","journal-title":"Acta. Orthop. Traumatol. Turc."},{"key":"10.1016\/j.intimp.2026.116938_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2024.104951","article-title":"Modulation of IL-6 receptor\/STAT3 downstream signaling in rheumatoid arthritis patients","volume":"141","author":"Cacciapaglia","year":"2025","journal-title":"Exp. Mol. Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116938_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250359","article-title":"Mast cells in type 2 skin inflammation: Maintenance and function","volume":"53","author":"Keith","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2026.116938_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2025.1668742","article-title":"The recent advances of mast cells in the pathogenesis of atopic dermatitis","volume":"6","author":"Xiao","year":"2025","journal-title":"Front. Allergy"},{"key":"10.1016\/j.intimp.2026.116938_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/srep05865","article-title":"Role of Tyk-2 in Th9 and Th17 cells in allergic asthma","volume":"4","author":"\u00dcbel","year":"2014","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2026.116938_bb0180","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/jcm14041312","article-title":"Therapeutic Advancements in Psoriasis and Psoriatic Arthritis","volume":"14","author":"Yi","year":"2025","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116938_bb0185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/10600280231153863","article-title":"Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis","volume":"58","author":"Truong","year":"2024","journal-title":"Ann. Pharmacother."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:30:40Z","timestamp":1791995440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926007848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S1567576926007848"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116938","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kirenol, a diterpene active component from Siegesbeckia orientalis, alleviates atopic dermatitis by suppressing TYK2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116938"}}